Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 5/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.46 |
| ▸ | THRA | P10827 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5704525 | 1.00 | ADRB2 (0.46) | ADRB2ADRB1THRATHRBHRH1 | |
| Acetic Acid SCHEMBL9302793 | 0.91 | THRA (0.44) | ADRB2ADRB1THRATHRB | |
| SCHEMBL11742522 | 0.88 | TAAR1 (0.53) | BCHETAAR1AOC3 | |
| SCHEMBL10937045 | 0.86 | ADRB2 (0.43) | ADRB2ADRB1THRATHRBBCHE | |
| SCHEMBL8957418 | 0.85 | HRH1 (0.44) | HRH1TAAR1AOC3SLC6A2SLC6A4 | |
| SCHEMBL7632660 | 0.85 | HIF1A (0.43) | ADRB2ADRB1HIF1AEPAS1SLC6A2 | |
| SCHEMBL30899680 | 0.85 | HIF1A (0.43) | ADRB2ADRB1HIF1AEPAS1SLC6A2 | |
| Stearic Acid SCHEMBL12485509 | 0.83 | CYSLTR2 (0.57) | THRATHRB | |
| SCHEMBL7637528 | 0.82 | HIF1A (0.41) | ADRB2ADRB1BCHEHIF1AEPAS1 | |
| SCHEMBL9383733 | 0.82 | ADRB2 (0.44) | ADRB2ADRB1THRATHRBBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 738 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | PISAK MEHMET NEVZAT (TR) | 2026-05-19 | — | — | US | claimed |
| US-20260016466-A1 | TEST PIECE FOR MEASURING ALBUMIN AND METHOD FOR MEASURING ALBUMIN | FUJIFILM CORPORATION (JP) | 2026-01-15 | — | — | US | claimed |
| WO-2025217418-A1 | SAMPLE PREPARATION FOR NUCLEIC ACIDS | Life Technologies Corporation (US) | 2025-10-16 | — | — | WO | claimed |
| CN-120015852-A | Preparation method of microporous layer slurry, gas diffusion layer and membrane electrode assembly | 国家电投集团氢能科技发展有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119592954-A | Aluminum etching solution and preparation method and application thereof | 湖北兴福电子材料股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119581579-A | Gas diffusion layer and preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2025-03-07 | — | — | CN | claimed |
| WO-2024195780-A1 | ALBUMIN MEASUREMENT TEST PIECE AND ALBUMIN MEASUREMENT METHOD | 富士フイルム株式会社 | 2024-09-26 | — | — | WO | claimed |
| EP-4178551-B1 | CURCUMINOID COMPOSITIONS WITH HIGH BIOAVAILABILITY | PISAK MEHMET NEVZAT (TR) | 2024-08-07 | — | — | EP | claimed |
| CN-117117209-B | Gas diffusion layer and preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2024-02-09 | — | — | CN | claimed |
| US-20240041793-A1 | CURCUMINOID COMPOSITIONS WITH HIGH BIOAVAILABILITY | PISAK MEHMET NEVZAT (TR) | 2024-02-08 | — | — | US | claimed |
| EP-1290158-A2 | PROCESSING OF PLASMID-CONTAINING FLUIDS | Pall Corporation (US) | 2003-03-12 | — | — | EP | claimed |
| US-6478881-B2 | CONTAINING WATER SOLUBLE ANIONIC POLYMER | VISTA SCIENTIFIC L.L.C. | 2002-11-12 | — | — | US | claimed |
| WO-2002011225-A1 | GAS SENSORS | CITY TECHNOLOGY LIMITED (GB) | 2002-02-07 | — | — | WO | claimed |
| WO-2001094573-A2 | PROCESSING OF PLASMID-CONTAINING FLUIDS | PALL CORPORATION (US) | 2001-12-13 | — | — | WO | claimed |
| US-20010020000-A1 | Contact lens cleaning solution | ELLIS JEANNE Y (US) | 2001-09-06 | — | — | US | claimed |
| US-6120794-A | OIL IN WATER EMULSION | UNIVERSITY OF PITTSBURGH (US) | 2000-09-19 | — | — | US | claimed |
| US-5981736-A | HOUSING WITH ADSORPTIVE MEDIA PACKED ON SIZE EXCLUSION MEDIA PACKED ON POROUS MEDIA; FOR CHROMATOGRAPHY AND ELUTION OF BIOLOGICAL MATERIAL IN APPROPRIATE BUFFER FOR FURTHER USE SUCH AS GENE TRANSFECTION OR ELECTROPHORESIS ANALYSIS | LIFE TECHNOLOGIES, INC. (US) | 1999-11-09 | — | — | US | claimed |
| EP-0470192-A4 | IMPROVED IMMUNOASSAY INCLUDING LYOPHILIZED REACTANT MIXTURE | — | 1992-03-11 | — | — | EP | claimed |
| EP-0470192-A1 | IMPROVED IMMUNOASSAY INCLUDING LYOPHILIZED REACTANT MIXTURE. | HYGEIA SCIENCES LTD (US) | 1992-02-12 | — | — | EP | claimed |
| WO-1990013637-A1 | IMPROVED IMMUNOASSAY INCLUDING LYOPHILIZED REACTANT MIXTURE | HYGEIA SCIENCES, INC. (US) | 1990-11-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260016466-A1 | TEST PIECE FOR MEASURING ALBUMIN AND METHOD FOR MEASURING ALBUMIN | ALB, S100P, MB | ADRB2 2092/4885ADRB1 3281/4885THRA 2245/4885 |
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | CNR1, GPR55, CNR2 | ADRB2 464/4885ADRB1 236/4885THRA 2155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.